ALISON MILLER: Open Payments
NPI 1952000580 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,221 in 182 payments from 19 companies in 2025. Trend: 2023 $897 · 2024 $3,031 · 2025 $3,221
Food & beverage: $3,136Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $835 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $444 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $276 |
| Janssen Biotech, Inc. | 7 | $275 |
| Ardelyx, Inc. | 10 | $195 |
| QOL Medical, LLC | 11 | $174 |
| PFIZER INC. | 9 | $142 |
| Lilly USA, LLC | 7 | $138 |
| Phathom Pharmaceuticals, Inc. | 8 | $124 |
| Regeneron Healthcare Solutions, Inc. | 6 | $117 |
Products named: RINVOQ, ENTYVIO, TREMFYA, XIFAXAN, IBSRELA, SKYRIZI, Sucraid, DUPIXENT.
Industry payments across NJ — which companies pay providers there.
